Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis.

Dengue virus produces a mild acute febrile illness, dengue fever (DF) and a severe illness, dengue hemorrhagic fever (DHF). The characteristic feature of DHF is increased capillary permeability leading to extensive plasma leakage in serous cavities resulting in shock. The pathogenesis of DHF is not fully understood. This paper presents a cascade of cytokines, that in our view, may lead to DHF. The main feature is the early generation of a unique cytokine, human cytotoxic factor (hCF) that initiates a series of events leading to a shift from Th1-type response in mild illness to a Th2-type response resulting in severe DHF. The shift from Th1 to Th2 is regulated by the relative levels of interferon-gamma and interleukin (IL)-10 and between IL-12 and transforming growth factor-beta, which showed an inverse relationship in patients with DF.

[1]  D. Ha,et al.  Tumor necrosis factor alpha levels in plasma and whole‐blood culture in dengue‐infected patients: Relationship between virus detection and pre‐existing specific antibodies , 1998, Journal of medical virology.

[2]  M. Sinniah,et al.  Augmented inflammatory cytokines in primary dengue infection progressing to shock. , 1995, Singapore medical journal.

[3]  B. Dewald,et al.  Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. , 1994, Cytokine.

[4]  A. Sampieri,et al.  Analysis of the local kinetics and localization of interleukin‐1α, tumour necrosis‘qc factor‐α and transforming growth factor‐β, during the course of experimental pulmonary tuberculosis , 1997 .

[5]  A. Pacsa,et al.  Role of interleukin-12 in patients with dengue hemorrhagic fever. , 2000, FEMS immunology and medical microbiology.

[6]  U. Chaturvedi,et al.  Effect of dengue virus infection on Fc-receptor functions of mouse macrophages. , 1983, The Journal of general virology.

[7]  T. Vitarana,et al.  Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. , 1991, The Ceylon medical journal.

[8]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[9]  A. Nisalak,et al.  Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. , 1991, The Journal of clinical investigation.

[10]  S. Kapoor,et al.  A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. , 1999, The Southeast Asian journal of tropical medicine and public health.

[11]  R. Dhawan,et al.  Breakdown of the blood-brain barrier during dengue virus infection of mice. , 1991, The Journal of general virology.

[12]  M. Sinniah,et al.  Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? , 1991, FEMS microbiology immunology.

[13]  S. Kapoor,et al.  SHIFT FROM A TH1-TYPE RESPONSE TO TH2-TYPE IN DENGUE HAEMORRHAGIC FEVER , 1999 .

[14]  P. Puccetti,et al.  Interleukin-12 in infectious diseases , 1997, Clinical microbiology reviews.

[15]  A. Pacsa,et al.  Sequential production of cytokines by dengue virus‐infected human peripheral blood leukocyte cultures , 1999, Journal of medical virology.

[16]  B. Seliger,et al.  Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. , 1998, Journal of immunology.

[17]  M. Sharma,et al.  Increased capillary permeability mediated by a dengue virus-induced lymphokine. , 1990, Immunology.

[18]  S. Lam,et al.  Dengue haemorrhagic fever , 1995 .

[19]  Duane J. Gubler,et al.  Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.

[20]  U. Chaturvedi,et al.  Production of nitrite by dengue virus‐induced cytotoxic factor , 1996, Clinical and experimental immunology.

[21]  A. Nisalak,et al.  Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severity , 1999, Journal of medical virology.

[22]  D. Hober,et al.  Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected Patients , 1993 .

[23]  Y. S. Lin,et al.  Immunopathogenesis of dengue virus infection. , 2001, Journal of biomedical science.

[24]  Chaturvedi,et al.  Profile of transforming growth factor‐beta 1 in patients with dengue haemorrhagic fever , 1999, International journal of experimental pathology.

[25]  S. Kapoor,et al.  Elevated levels of IL‐8 in dengue hemorrhagic fever , 1998, Journal of medical virology.

[26]  U. Chaturvedi,et al.  Respiratory Burst by Dengue-Virus-Induced Cytotoxic Factor , 1998, Medical Principles and Practice.

[27]  V. Strand,et al.  Combination biologic therapy. , 1999, Clinical and experimental rheumatology.

[28]  E. Chungue,et al.  Plasma levels of tumour necrosis factor a and transforming growth factor β-1 in children with dengue 2 virus infection in French Polynesia , 1998 .

[29]  Active immunization by a dengue virus‐induced cytokine , 1994, Clinical and experimental immunology.

[30]  S. A. Oliveira,et al.  Increased pro-inflammatory cytokines (TNF-alpha and IL-6) and anti-inflammatory compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever. , 1999, Memorias do Instituto Oswaldo Cruz.

[31]  U. Chaturvedi,et al.  Obligatory role of macrophages in dengue virus antigen presentation to B lymphocytes. , 1989, Immunology.

[32]  D. Ireland,et al.  IL-12 and Viral Infections , 1998, Cytokine & Growth Factor Reviews.

[33]  D. Kwiatkowski,et al.  Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. , 1998, The Journal of infectious diseases.

[34]  H. Young,et al.  IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. , 1999, Journal of immunology.

[35]  N. Horwood,et al.  Interleukin-18: perspectives on the newest interleukin. , 1998, Cytokine & growth factor reviews.